The page is the record's research on the issuer — no analyst, no rating, no view. # Pyxis Oncology, Inc. (NASDAQ: PYXS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Pyxis Oncology, Inc., listed on NASDAQ under ticker PYXS, with ISIN US7473241013. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, the jurisdiction is United States, Delaware, and the segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 57 filings across 31 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 6.5 days, and the latest filing is dated 2026-11-06, 2 days before the record date. The latest filing is of type directors_dealings. The NASDAQ median gap is 6.0 days across 4359 issuers, and the NASDAQ median latency is 5.0 days. The 2834 Pharmaceutical Preparations sector median gap is 6.0 days across 526 issuers, and the sector median latency is 4.0 days. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record, and the record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the investor-relations pages read, and the count is 0. ## Open research No openly published research notes were found, and the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001782223.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/PYXS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/PYXS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/PYXS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp